Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Texting moms after birth could slash ER trips, new study hopes

NCT ID NCT06273436

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study compares standard postpartum care to a technology-based program called H.E.A.R. for Mamas, which uses text messages and phone calls to screen new mothers for complications. About 2,900 Medicaid-insured women in South Carolina will take part. The goal is to see if this approach reduces emergency department visits in the first six weeks after delivery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
H.E.A.R. for Mamas (text/phone-based screening and feedback)
What this could lead to
If successful, this could show that simple text/phone check-ins help catch postpartum complications early and reduce unnecessary ER visits.
What could go wrong
This is a large trial but still early in testing a behavioral intervention. Results may not apply to people without Medicaid or outside South Carolina.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 2,894 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2024

Expected to finish

Mar 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 to 49 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for Postpartum Women * Postpartum woman within approximately 2 weeks of delivering a baby of gestational age ≥ 26 weeks in South Carolina. * Aged 16-49 years old. * Insured by Medicaid. Exclusion Criteria for Postpartum Women * Plans to relocate outside of SC anytime during the postpartum year. * Plans to discontinue Medicaid health insurance during the postpartum year. * Speaks a language other than English or Spanish. * Incarcerated/pending incarceration during peripartum period. * Currently institutionalized. * Enrolled in current MUSC study funded by PCORI (#Pro00123833) * Does not have and/or does not wish to use their personal cell phone for the study. Inclusion Criteria for Obstetric Providers and Hospital Administrators \- OB provider working at a delivery hospital in SC and directly involved in the care of postpartum women; or hospital administrator working in a delivery hospital in SC and job responsibilities relate to the postpartum unit. Exclusion Criteria for Obstetric Providers and Hospital Administrators * Less than 1 month of HEAR 4 Mamas experience if involved in the hospital where participants are recruited from. * Unable or unwilling to commit to completing surveys or an interview. * Speaking a language other than English.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postpartum complication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Emergencies Episodic Ataxia, Type 1 puerperal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Medical University of South Carolina

    RECRUITING

    Charleston, South Carolina, 29425, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.